Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Aligos Therapeutics Inc market cap is $61.9M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aligos Therapeutics Inc 52 week high is $1.38 as of April 26, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aligos Therapeutics Inc 52 week low is $0.5388 as of April 26, 2024.
Aligos Therapeutics Inc stock price today is $0.818.
Aligos Therapeutics Inc stock price yesterday was $0.829.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Aligos Therapeutics Inc P/B ratio is 0.6671.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Aligos Therapeutics Inc's EBITDA is 0.48.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Aligos Therapeutics Inc 50-day moving average is $0.9013.
Aligos Therapeutics Inc has 66 employees.